Myocardial Viability Testing to Guide Coronary Revascularization

Area of Science:

• Cardiology
• Medical Imaging
• Nuclear Medicine

Background:

• Left ventricular dysfunction is a key prognostic factor in coronary artery disease (CAD).
• Revascularization improves survival in CAD patients compared to medical therapy alone.
• Identifying myocardial viability is crucial for selecting patients for revascularization.

Purpose of the Study:

• To review the role of myocardial viability testing in guiding revascularization decisions for patients with CAD.
• To highlight common imaging modalities used for viability assessment.
• To emphasize the utility of viability testing in chronic total occlusion interventions.

Main Methods:

• Review of current literature on myocardial viability assessment.
• Discussion of imaging techniques including single-photon emission computed tomography (SPECT), dobutamine stress echocardiography (DSE), cardiac MRI, and F18-fluorodeoxyglucose Positron Emission Tomography (FDG-PET).

Main Results:

• Myocardial viability testing accurately identifies patients likely to benefit from revascularization.
• SPECT, DSE, cardiac MRI, and FDG-PET are established methods for assessing myocardial viability.
• Viability assessment aids in selecting patients for interventions, particularly for chronic total occlusions.

Conclusions:

• Myocardial viability testing is essential for optimizing revascularization strategies in CAD.
• The choice of imaging modality depends on clinical context and availability.
• Accurate viability assessment improves patient selection for interventions and potentially enhances survival outcomes.